Expression and Prognostic Role of E2F2 in Hepatocellular Carcinoma

References

• Dutta R, Mahato RI. Recent advances in hepatocellular carcinoma therapy. Pharmacol Ther. 2017;173:106–117. doi:10.1016/j.pharmthera.2017.02.010
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.21442
   PubMed Web of Science ®Google Scholar
• Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul J. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Sposito C, Mazzaferro V. The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future. Hepatobiliary Surg Nutr. 2018;7(6):487–489. doi:10.21037/hbsn.2018.10.06
   PubMed Web of Science ®Google Scholar
• Zhang DY, Zou X-J, Cao C-H, et al. Identification and functional characterization of long non-coding RNA MIR22HG as a tumor suppressor for hepatocellular carcinoma. Theranostics. 2018;8(14):3751–3765. doi:10.7150/thno.22493
   PubMed Web of Science ®Google Scholar
• Xiang DM, Sun W, Zhou T, et al. Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance. Gut. 2019;68(10):1858–1871. doi:10.1136/gutjnl-2018-317440
   PubMed Web of Science ®Google Scholar
• Novy M, Pohn R, Andorfer P, et al. EAPP, a novel E2F binding protein that modulates E2F-dependent transcription. Mol Biol Cell. 2005;16(5):2181–2190. doi:10.1091/mbc.e04-11-0975
   PubMed Web of Science ®Google Scholar
• Slansky JE, Farnham PJ. Introduction to the E2F family: protein structure and gene regulation. Curr Top Microbiol Immunol. 1996;208:1–30. doi:10.1007/978-3-642-79910-5_1
   PubMed Web of Science ®Google Scholar
• Bai Q, Li L, Chen F, et al. Suppression of circular RNA Hsa_circ_0109320 attenuates non-small cell lung cancer progression via MiR-595/E2F7 axis. Med Sci Monit. 2020;26:e921200. doi:10.12659/MSM.921200
   PubMed Web of Science ®Google Scholar
• Yao H, Lu F, Shao Y. The E2F family as potential biomarkers and therapeutic targets in colon cancer. PeerJ. 2020;8:e8562. doi:10.7717/peerj.8562
   PubMed Web of Science ®Google Scholar
• Wei J, Yin Y, Deng Q, et al. Integrative analysis of microRNA and gene interactions for revealing candidate signatures in prostate cancer. Front Genet. 2020;11:176. doi:10.3389/fgene.2020.00176
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. Doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• He Y, Yu X, Li J, et al. Role of m(5) C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma. Am J Transl Res. 2020;12(3):912–922.
   PubMed Web of Science ®Google Scholar
• He Y, Dang Q, Li J, et al. Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set. Aging (Albany NY). 2020;12(1):965–977. doi:10.18632/aging.102669
   PubMedGoogle Scholar
• Xue C, He Y, Zhu W, et al. Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma. Am J Transl Res. 2018;10(12):4152–4162.
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. doi:10.1245/s10434-010-0985-4
   PubMed Web of Science ®Google Scholar
• Vasaikar SV, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956–D963. doi:10.1093/nar/gkx1090
   PubMed Web of Science ®Google Scholar
• Dennis G, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):P3. doi:10.1186/gb-2003-4-5-p3
   PubMed Web of Science ®Google Scholar
• Unberath P, Knell C, Prokosch H-U, et al. Developing new analysis functions for a translational research platform: extending the cBioPortal for cancer genomics. Stud Health Technol Inform. 2019;258:46–50.
   PubMedGoogle Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23(29):5282–5294. doi:10.3748/wjg.v23.i29.5282
   PubMed Web of Science ®Google Scholar
• Marquardt JU, Andersen JB, Thorgeirsson SS. Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer. 2015;15(11):653–667. doi:10.1038/nrc4017
   PubMed Web of Science ®Google Scholar
• Sun W, Cabrera R. Systemic treatment of patients with advanced, unresectable hepatocellular carcinoma: emergence of therapies. J Gastrointest Cancer. 2018;49(2):107–115. doi:10.1007/s12029-018-0065-8
   PubMed Web of Science ®Google Scholar
• Yu H, Li Z, Wang M. Expression and prognostic role of E2F transcription factors in high-grade glioma. CNS Neurosci Ther. 2020;26(7):741–753. doi:10.1111/cns.13295
   PubMed Web of Science ®Google Scholar
• Wang X, Ding Y, Wang J, et al. Identification of the key factors related to bladder cancer by lncRNA-miRNA-mRNA three-layer network. Front Genet. 2019;10:1398. doi:10.3389/fgene.2019.01398
   PubMed Web of Science ®Google Scholar
• Wang H, Wang X, Xu L, et al. Integrated analysis of the E2F transcription factors across cancer types. Oncol Rep. 2020;43(4):1133–1146. doi:10.3892/or.2020.7504
   PubMed Web of Science ®Google Scholar
• Li Y, Huang J, Yang D, et al. Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer. Oncol Lett. 2018;15(6):9216–9230. doi:10.3892/ol.2018.8514
   PubMed Web of Science ®Google Scholar
• Chang JL, Chen T-H, Wang C-F, et al. Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer. Exp Cell Res. 2006;312(7):962–973. doi:10.1016/j.yexcr.2005.12.015
   PubMed Web of Science ®Google Scholar
• Bi N, Sun Y, Lei S, et al. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis. Oncol Rep. 2020;44(2):611–627. doi:10.3892/or.2020.7634
   PubMed Web of Science ®Google Scholar
• Gao X, Wen X, He H, et al. Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells. PeerJ. 2020;8:e9078. doi:10.7717/peerj.9078
   PubMed Web of Science ®Google Scholar
• Yang WX, Pan YY, You CG. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 may be potential therapeutic targets for hepatocellular carcinoma using integrated bioinformatic analysis. Biomed Res Int. 2019;2019:1245072. doi:10.1155/2019/1245072
   PubMed Web of Science ®Google Scholar
• Kitajima S, Li F, Takahashi C. Tumor milieu controlled by RB tumor suppressor. Int J Mol Sci. 2020;21(7):2450. doi:10.3390/ijms21072450
   PubMed Web of Science ®Google Scholar
• Manicum T, Ni F, Ye Y, et al. Prognostic values of E2F mRNA expression in human gastric cancer. Biosci Rep. 2018;38(6). doi:10.1042/BSR20181264
   PubMed Web of Science ®Google Scholar
• Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer. 2009;9(11):785–797. doi:10.1038/nrc2696
   PubMed Web of Science ®Google Scholar
• Casimiro MC, Crosariol M, Loro E, et al. Cyclins and cell cycle control in cancer and disease. Genes Cancer. 2012;3(11–12):649–657. doi:10.1177/1947601913479022
   PubMedGoogle Scholar
• Lepère-Douard C, Trotard M, Le Seyec J, et al. The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity. J Virol. 2009;83(22):11819–11829. doi:10.1128/JVI.01026-09
   PubMed Web of Science ®Google Scholar
• Gao Q, Qiu S-J, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25(18):2586–2593. doi:10.1200/JCO.2006.09.4565
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21(8):938–945. doi:10.1038/nm.3909
   PubMed Web of Science ®Google Scholar
• Franklin RA, Liao W, Sarkar A, et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344(6186):921–925. doi:10.1126/science.1252510
   PubMed Web of Science ®Google Scholar